Pancreaze
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(888) 998-4887Website
www.pancreaze.comRevenue
<$5 MillionIndustry
About Pancreaze
Is Pancreaze your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Pancreaze launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Pancreaze has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Pancreaze has new funding data
Earning: See what the market has to say on Pancreaze recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Pancreaze
Pancreaze, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Pancreaze is spiking on competitors!
Click to see if Pancreaze had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Pancreaze as Masked Content
Find 3 more new buyers
Compare Similar Companies to Pancreaze
Compare insights from companies similar to Pancreaze, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Pancreaze is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pancreaze is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pancreaze.
Pancreaze Tech Stack
A closer look at the technologies used by Pancreaze
Pancreaze News & Media
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 44th Annual J.P. Morgan Healthcare Conference
CAMPBELL, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, today announced it will provide updates to its pipeline and key program milestones during the 44th Annual J.P. Morgan Healthcare Conference 2026.Clinical Data Published at ASCO Support the Potential of VIVUS’ PANCREAZE® to Stabilize Weight and Improve Gastrointestinal Outputs in Patients with Pancreatic Cancer
CAMPBELL, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, announces the publication of new clinical trial data demonstrating that PANCREAZE® (pancrelipase) helped to stabilize weight in patients undergoing chemotherapy for the treatment of pancreatic ductal adenocarcinoma (PDAC) who have cachexia (wasting syndVIVUS Reports First Quarter 2020 Financial Results
Company to host conference call today at 4:30pm ETVIVUS Reports Fourth Quarter and Full Year 2019 Financial Results
- Company to host conference call today at 4:30pm ET -
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pancreaze
PANCREAZE is a prescription medication designed to treat exocrine pancreatic insufficiency (EPI) in both adults and pediatric patients. It helps individuals who struggle to digest food due to insufficient enzyme production by the pancreas, alleviating symptoms such as stomach pain, gas, and diarrhea. The product is available in various strengths an... Read More